Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8814945 | Journal of Affective Disorders | 2018 | 32 Pages |
Abstract
These preliminary pilot data are promising with a greater than two-fold reduction in SI following ketamine infusions. They demonstrate that six serial ketamine infusions may be safe and feasible. These findings support the need for large scale randomized controlled trials to confirm the efficacy of serial ketamine for treatment of SI in “real-world” settings.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Mark Sinyor, Marissa Williams, Sue Belo, Beverley Orser, Margaret Vincent, Linda Mah, Carlos Jr, Saulo Castel, Anthony J. Levitt, Ayal Schaffer,